Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting
Provided By GlobeNewswire
Last update: Jan 21, 2025
– Plans for filing an IND was agreed with the FDA in a recent meeting –
– Positive preclinical results of the small-diameter ATEV were recently presented at The American Heart Association’s Scientific Sessions 2024 meeting –
Read more at globenewswire.com
